Scholarly Index
Kenji Kosaka
Chugai Pharma (United States); 25,685 total citations; 380 total publications; best world rank #31
Chugai Pharma (United States)
25,685Total citations
380Total publications
60H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ginkgo biloba and Cashew Applications | Lifetime | 31 | US 14 | 98.00 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 463 | US 174 | 98.50 |
| Alzheimer's disease research and treatments | Lifetime | 685 | US 337 | 98.31 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 381 | US 148 | 96.96 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 565 | US 216 | 96.07 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 622 | US 189 | 94.45 |
| Lysosomal Storage Disorders Research | Lifetime | 561 | US 212 | 94.91 |
| Neurological and metabolic disorders | Lifetime | 395 | US 170 | 93.14 |
| Neurological diseases and metabolism | Lifetime | 589 | US 217 | 93.78 |
| Cerebrovascular and genetic disorders | Lifetime | 234 | US 62 | 91.52 |